{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:40:35Z","timestamp":1792708835318,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:11:18Z","timestamp":1783437078000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AMPK-driven immunometabolic reprogramming enhances CD19+CD21hiCD24hi regulatory B-cell\u2013mediated suppression of atopic dermatitis"],"prefix":"10.1016","author":[{"given":"Seung Taek","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hwa","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.06.015_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: an expanding therapeutic pipeline for a complex disease","volume":"21","author":"Bieber","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jid.2023.03.1680","article-title":"Excessive production of hydrogen peroxide in mitochondria contributes to atopic dermatitis","volume":"143","author":"Minzaghi","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.06.015_bib3","article-title":"Imidazole propionate ameliorates atopic dermatitis-like skin lesions by inhibiting mitochondrial ROS and mTORC2","volume":"15","author":"Kim","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","article-title":"Metabolic pathways that control skin homeostasis and inflammation","volume":"26","author":"Cibrian","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2026.06.015_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41467-018-02911-y","article-title":"CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells","volume":"9","author":"Oleinika","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.06.015_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109548118","article-title":"IL-27\u2013producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases","volume":"118","author":"Choi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10409238.2016.1215288","article-title":"The PI3K pathway in B cell metabolism","volume":"51","author":"Jellusova","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jaci.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","article-title":"The emerging field of regulatory B cell immunometabolism","volume":"33","author":"Rosser","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2026.06.015_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","article-title":"Thioredoxin is a metabolic rheostat controlling regulatory B cells","volume":"25","author":"Bradford","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1186\/s12967-023-04772-6","article-title":"The role of AMPK in macrophage metabolism, function and polarisation","volume":"21","author":"Cui","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaci.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-171296","article-title":"Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease","volume":"8","author":"Curry","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jaci.2026.06.015_bib16","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708307","article-title":"The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting","volume":"10","author":"Hall","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaci.2026.06.015_bib17","article-title":"AICAR attenuates postoperative abdominal adhesion formation by inhibiting oxidative stress and promoting mesothelial cell repair","volume":"17","author":"Wu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","article-title":"Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells","volume":"31","author":"Rosser","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2026.06.015_bib19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.06.015_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41989","article-title":"Comparative study of mouse models of atopic dermatitis","volume":"11","author":"Ye","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.jaci.2026.06.015_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.etap.2017.12.025","article-title":"A novel mouse model of atopic dermatitis that is T helper 2 (Th2)-polarized by an epicutaneous allergen","volume":"58","author":"Park","year":"2018","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jaci.2026.06.015_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2007.02.062","article-title":"Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice","volume":"565","author":"Yatsuzuka","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2026.06.015_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.06.015_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A Regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"Carter","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2026.06.015_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.imlet.2014.01.008","article-title":"Persistent inflammation in HIV infection: established concepts, new perspectives","volume":"161","author":"Nasi","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2026.06.015_bib31","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41467-021-22230-z","article-title":"The survival and function of IL-10\u2013producing regulatory B cells are negatively controlled by SLAMF5","volume":"12","author":"Radomir","year":"2021","journal-title":"Nat Commun"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600480X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600480X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:27:11Z","timestamp":1792708031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492600480X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S009167492600480X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.015","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMPK-driven immunometabolic reprogramming enhances CD19+CD21hiCD24hi regulatory B-cell\u2013mediated suppression of atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}